Follow on Google News News By Tag * American Video Teleconferencing * Avot.pk * Cerium * Gas Exploration * Geological * Lajuene * Lanthanum * Mekinac * More Tags... Industry News Country(s) Industry News
Follow on Google News | ZANE, PPWE, DIET, AVOT, PARD - CRWEWallstreet.com Stock Report! February 15th 2011Limits on Chinese exports are creating opportunities for non-Chinese ventures.
By: Hanson Stepped-up mining operations and expanded manufacturing schedules in Africa, Australia, Canada, Malaysia, America, Vietnam and elsewhere may well provide supply-chain choices to China, which controls more than 95 % of the world’s rare earths. The U.S. House of Representatives, worried the U.S. military could possibly become dependent on Chinese-made electronics, approved H.R. 6160, the Rare Earths and Critical Materials Revitalization Act of 2010. Japan, one of the countries hardest hit by the tightening of rare earth supplies, has fast-tracked efforts both to recycle rare earths from discarded electronics and also to develop alternate options to the materials for use in electric engines and the nickel-metal- Limits on Chinese exports are creating opportunities for non-Chinese ventures. American Video Teleconferencing Corp. (Pink Sheets:AVOT) AVOT is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. The property has been dormant since the 1960's when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City. This property is only one of several advanced stage properties the company has under consideration in the province of Quebec. To contact the company, Email at dealseekers10@ Ediets.com Inc. announced that Jennifer Hartnett has been appointed Chief Marketing Officer. Reporting directly to Kevin McGrath, President and Chief Executive Officer of eDiets.com, Ms. Hartnett will be responsible for all of the Company's marketing initiatives, with a focus on customer acquisition, retention and reactivation. "Strengthening our strategic marketing efforts is critical to growing our brand during this important time for our business," said Kevin McGrath, President and Chief Executive Officer. eDiets.com, Inc. engages in developing and marketing Internet-based diet and fitness programs to consumers and businesses primarily in North America. There is much in the life of oil and natural gas. When you take time and think about it, it’s awesome how many things get their start from oil and natural gas. Comfy synthetic fabrics we wear all year. Medicines that help us feel better. Transportation fuels that help us get from place to place. Fertilizers that make our gardens grow. And just about every toy our children play with. Oil and natural gas - they’re the stuff of life. More: Proper Power & Energy, Inc. (OTCBB-PPWE.OB) "The timing to acquire oil and gas properties while gas prices are low couldn't be better. Additionally, the availability of this funding for developing Proper Power's Kentucky and Utah oil prospects will accelerate 2011 revenues and leasehold acreage growth dramatically. We anticipate feedback from both of the financing groups before the end of this month," stated Andrew J. Kacic, President of Proper Power & Energy. More about PPWE at: www.properpower.com Poniard Pharmaceuticals, Inc. announced the sale of 4,914,632 shares of its common stock to Small Cap Biotech Value, Ltd. for gross proceeds of $1,895,814, or approximately $0.39 per share, under its existing committed equity financing facility with Small Cap Biotech Value, Ltd. The Company intends to use net proceeds from this sale for working capital and other general corporate purposes. The securities described above were sold by Poniard Pharmaceuticals pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission. Poniard Pharmaceuticals, Inc., together with its subsidiary, NeoRx Manufacturing Group, Inc., focuses on the development and commercialization of cancer therapeutics. Sign Up For Free Stock Alerts At http://crwewallstreet.com/ ************************************************************ THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/ End
Account Email Address Disclaimer Report Abuse
|
|